Not sure which big Pharma will be interested in this device, a device company maybe
noted Wilson’s recent report more cautious target now 25c and says what a number of us have said before that their current data is limited and lacks statistical clout (their words) and they’ll need RCT for US approval and wider reimbursement. Wilson’s think 200 sample size over 3.5 years. don’t know how theyve estimated that but I guess that’s possible maybe best case. But OSL need seriously more cash in bank to run such a study.
OSL Price at posting:
9.6¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)